Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Snyder

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNAJean-Baptiste Dupont, Benoit Tournaire, Christophe Georger, et al.
Human Gene Therapy|October 3, 2014
Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard materialEduard Ayuso, Véronique Blouin, Martin Lock, et al.
Human Gene Therapy|May 22, 2010
Characterization of a recombinant adeno-associated virus type 2 Reference Standard MaterialMartin Lock, Susan McGorray, Alberto Auricchio, et al.
The New England Journal of Medicine|October 10, 2019
Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJinkuk Kim, Chunguang Hu, Christelle Moufawad El Achkar, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNAJean-Baptiste Dupont, Benoit Tournaire, Christophe Georger, et al.
Human Gene Therapy|October 3, 2014
Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard materialEduard Ayuso, Véronique Blouin, Martin Lock, et al.
Human Gene Therapy|May 22, 2010
Characterization of a recombinant adeno-associated virus type 2 Reference Standard MaterialMartin Lock, Susan McGorray, Alberto Auricchio, et al.
The New England Journal of Medicine|October 10, 2019
Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJinkuk Kim, Chunguang Hu, Christelle Moufawad El Achkar, et al.
Pageof 12